Megan Sredl1, Aaron T Fleischauer2, Zack Moore1, David L Rosen3, Asher J Schranz3. 1. Epidemiology Section, North Carolina Department of Health and Human Services, Raleigh, North Carolina, USA. 2. Epidemiology Section, North Carolina Department of Health and Human Services, Raleigh, North Carolina, USA,Career Epidemiology Field Officer, Division of State and Local Readiness, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. 3. Institute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Abstract
BACKGROUND: While increases in overdoses, viral hepatitis, and endocarditis associated with drug use have been well-documented in North Carolina, the full scope of invasive drug-related infections (IDRIs) has not. We characterized trends in IDRIs among hospitalized patients in North Carolina. METHODS: We compared invasive infections that were related or not related to drug use among hospitalized patients aged 18-55 years based on retrospective review of administrative records from 2010-2018. Hospitalizations for endocarditis, central nervous system/spine infections, osteomyelitis, and septic arthritis were labeled as IDRIs if discharge codes included opioid and/or amphetamine misuse. Trends, rates, and distributions were calculated. RESULTS: Among 44 851 hospitalizations for the specified infections, 2830 (6.3%) were IDRIs. The proportion of infections attributable to drug use increased from 1.5% (2010) to 13.1% (2018), and the rate grew from 1.2 to 15.1 per 100 000. Compared with those who had non-drug-related infections, patients with IDRIs were younger (median age, 35 vs 46 years), more likely to be non-Hispanic white (81% vs 56%), and had longer hospitalizations (median, 8 vs 6 days). 43% of hospitalizations for IDRIs involved infective endocarditis. CONCLUSIONS: The rate of IDRIs in North Carolina increased substantially during 2010-2018, indicating an urgent need for enhanced infection prevention, harm reduction, and addiction services aimed at community and inpatient settings.
BACKGROUND: While increases in overdoses, viral hepatitis, and endocarditis associated with drug use have been well-documented in North Carolina, the full scope of invasive drug-related infections (IDRIs) has not. We characterized trends in IDRIs among hospitalized patients in North Carolina. METHODS: We compared invasive infections that were related or not related to drug use among hospitalized patients aged 18-55 years based on retrospective review of administrative records from 2010-2018. Hospitalizations for endocarditis, central nervous system/spine infections, osteomyelitis, and septic arthritis were labeled as IDRIs if discharge codes included opioid and/or amphetamine misuse. Trends, rates, and distributions were calculated. RESULTS: Among 44 851 hospitalizations for the specified infections, 2830 (6.3%) were IDRIs. The proportion of infections attributable to drug use increased from 1.5% (2010) to 13.1% (2018), and the rate grew from 1.2 to 15.1 per 100 000. Compared with those who had non-drug-related infections, patients with IDRIs were younger (median age, 35 vs 46 years), more likely to be non-Hispanic white (81% vs 56%), and had longer hospitalizations (median, 8 vs 6 days). 43% of hospitalizations for IDRIs involved infective endocarditis. CONCLUSIONS: The rate of IDRIs in North Carolina increased substantially during 2010-2018, indicating an urgent need for enhanced infection prevention, harm reduction, and addiction services aimed at community and inpatient settings.
Authors: Sarah E Rudasill; Yas Sanaiha; Alexandra L Mardock; Habib Khoury; Hanning Xing; James W Antonios; James A McKinnell; Peyman Benharash Journal: J Am Coll Cardiol Date: 2019-02-12 Impact factor: 24.094
Authors: Alysse G Wurcel; Jordan E Anderson; Kenneth K H Chui; Sally Skinner; Tamsin A Knox; David R Snydman; Thomas J Stopka Journal: Open Forum Infect Dis Date: 2016-07-26 Impact factor: 3.835
Authors: Salequl Islam; Damani A Piggott; Alberto Moriggia; Jacquie Astemborski; Shruti H Mehta; David L Thomas; Gregory D Kirk Journal: Harm Reduct J Date: 2019-06-17
Authors: Sean T Allen; Suzanne M Grieb; Allison O'Rourke; Ryan Yoder; Elise Planchet; Rebecca Hamilton White; Susan G Sherman Journal: Harm Reduct J Date: 2019-05-21
Authors: Megan E Gray; Elizabeth T Rogawski McQuade; W Michael Scheld; Rebecca A Dillingham Journal: BMC Infect Dis Date: 2018-10-24 Impact factor: 3.090
Authors: David Goodman-Meza; Amber Tang; Babak Aryanfar; Sergio Vazquez; Adam J Gordon; Michihiko Goto; Matthew Bidwell Goetz; Steven Shoptaw; Alex A T Bui Journal: Open Forum Infect Dis Date: 2022-09-12 Impact factor: 4.423
Authors: Yoelkys Morales; Emma Smyth; Julia Zubiago; Benjamin Bearnot; Alysse G Wurcel Journal: Open Forum Infect Dis Date: 2022-10-19 Impact factor: 4.423
Authors: Ayesha Appa; Meredith Adamo; Stephenie Le; Jennifer Davis; Lisa Winston; Sarah B Doernberg; Henry Chambers; Marlene Martin; Nancy K Hills; Phillip O Coffin; Vivek Jain Journal: Clin Infect Dis Date: 2022-01-29 Impact factor: 9.079
Authors: Mary C Figgatt; Zach R Salazar; Louise Vincent; Diannee Carden-Glenn; Kelly Link; Lauren Kestner; Tyler Yates; Asher Schranz; Elizabeth Joniak-Grant; Nabarun Dasgupta Journal: Harm Reduct J Date: 2021-07-30